News and Events

View our monthly calendar for upcoming innovation information sessions, seminars, symposia and other events hosted by Enterprise Innovation and selected ecosystem partners.

Tracking a Protein’s Fleeting Shape Changes

April 17, 2024

Researchers at Weill Cornell Medicine have developed a powerful, new technique to generate “movies” of changing protein structures and speeds of up to 50 frames per second.

Researchers Produce Grafts that Replicate the Human Ear

April 1, 2024

Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that looks and feels natural. The study, published online in Acta Biomaterialia on March 16, offers the promise of grafts with well-defined anatomy and the correct biomechanical properties for those who are born with a congenital malformation or who lose an ear later in life.

2024 Health Hackathon Yields Innovative Solutions for Enhancing Patient Safety

March 21, 2024

The 2024 Health Hackathon brought together 185 students with diverse backgrounds from Cornell and 26 other universities—in just 36 hours, they addressed critical safety challenges facing patients today.

NSF Awards Grant for Evolution-inspired Design of Therapeutic RNAs

March 19, 2024

A team led by Dr. Samie Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a three-year, $1.65 million grant for RNA research under a biotechnology-development program run by the U.S. National Science Foundation.

Advancing Neurosurgical Innovations Through Mentor-Mentee Collaborations

March 11, 2024

Dr. Susan Pannullo, professor of clinical neurological surgery, considers it an honor and duty to support the next generation of neurosurgeons and help them reach their personal and professional goals. She met a like-minded mentee, Dr. Mohammed Fouda, fellow in neurological surgery. Both doctors have a keen interest in advancing neurosurgical technologies and team up to improve patient outcomes.

Conference Showcases Biomedical Innovation at the Intersection of Business and Science

March 7, 2024

The 2024 Startup Symposium & InvestConnect Conference celebrated scientific inquiry and the entrepreneurial spirit.

Structural Study Points the Way to Better Malaria Drugs

January 18, 2024

Structural insights into a potent antimalarial drug candidate’s interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new study by researchers at Weill Cornell Medicine and Van Andel Institute.

Cross-Disciplinary Collaborations Catalyze Serial Entrepreneurship

December 19, 2023

Dr. Jason Spector, chief of the Division of Plastic and Reconstructive Surgery at Weill Cornell Medicine, is a prolific inventor and serial entrepreneur with multiple patents and a global patent portfolio. In this conversation, Dr. Spector shared with Enterprise Innovation and fellow Weill Cornell Medicine clinicians his journey of becoming a serial entrepreneur. 

Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium

December 13, 2023

San Francisco and New York — Dec. 13, 2023 — The Parker Institute for Cancer Immunotherapy (PICI), the largest concentration of immuno-oncology (IO) expertise in the world, announced it has added Weill Cornell Medicine to its network of preeminent academic and medical research institutions at the forefront of the fight against cancer.

Accelerating BioVenture Innovation Participants Pitch Tri-Institutional Technologies to Early-Stage Venture Capitalists

December 12, 2023

BioVenture eLab celebrated the hard work of its 2023 Accelerating BioVenture Innovation cohort with a pitch event on Dec. 6 in Uris Auditorium. The group of graduate students, postdoctoral trainees and clinicians from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and The Rockefeller University received 12 weeks of intense didactic instruction. They then spent three weeks putting their knowledge about intellectual property, research and development, and market research into polishing investor pitches for the Tri-I inventions that formed the basis of their experimental NewCos.
Read the latest news about Enterprise Innovation and Weill Cornell Medicine.

Weill Cornell Medicine Enterprise Innovation 1155 York Ave. New York, NY 10065 Phone: (646) 962-7045